United States, May 7 -- The U.S. Food and Drug Administration announced that it is piloting one-day inspectional assessments, as part of a broader initiative to make its inspectional resources more targeted and efficient. As part of this pilot, which launched in April, the agency is conducting shorter, focused screening assessments to complement standard FDA inspections. One-day inspectional assessments also support the development of more robust risk models across FDA programs. Data gathered through these assessments-such as recurring compliance themes, facility-specific risk scores, and discrepancies between registered and actual operations-can be used to better target future oversight activities.The pilot is being conducted across multip...